The three-dimensional structure of peptide-MHC complexes

Annual Review of Immunology

Volumn 13, Issue , 1995, Pages 587-622

  Madden, Dean R ^a  

^a MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

antigen presentation; immune system; major histocompatibility complex; T cell recognition; X ray crystallography

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY;

EID: 0028943275     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.iy.13.040195.003103     Document Type: Review

References (96)

1. Hansen TH, Sachs DH. 1989. The major histocompatibility complex. In Fundamental Immunology, ed. WE Paul, pp. 445-87. New York: Raven
2. Allen PM. 1994. Peptides in positive and negative selection: a delicate balance. Cell 76:593-96
3. Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Köppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips RE, McMichael AJ. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403-7
4. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-10
5. Bjorkman PJ, Strominger JL, Wiley DC. 1985. Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes. J. Mol. Biol. 186:205-10
6. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. 1987. Structure of the human class I histocompatibility antigen HLA-A2. Nature 329:506-12
7. Madden DR, Saper MA, Garrett TPJ, Bjorkman PJ, Strominger JL, Wiley DC. 1989. Comparison of orthorhombic and monoclinic crystal structures of HLA-A2. Cold Spring Harbor Symp. Quant. Biol. 54:353-59
8. Saper MA, Bjorkman PJ, Wiley DC. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219:277-319
9. Garboczi DN, Madden DR, Wiley DC. 1994. Five viral peptide-HLA-A2 cocrystals: simultaneous space group determination and X-ray data collection. J. Mol. Biol. 239:581-87
10. Madden DR, Garboczi DN, Wiley DC. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693-708
11. Collins EJ, Garboczi DN, Wiley DC. 1994. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371:626-29
12. Garrett TPJ, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692-96
13. Guo H-C, Jardetzky TS, Garrett TPJ, Lane WS, Strominger JL, Wiley DC. 1992. Dif-ferent length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360:364-66
14. Silver ML, Guo H-C, Strominger JL, Wiley DC. 1992. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 360:367-69
15. Gorga JC, Madden DR, Prendergast JK, Wiley DC, Strominger JL. 1992. Crystallization and preliminary X-ray diffraction studies of the human major histocompatibility antigen HLA-B27. Proteins 12:87-90
16. Madden DR, Gorga JC, Strominger JL, Wiley DC. 1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321-25
17. Madden DR, Gorga JC, Strominger JL, Wiley DC. 1992. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035-48
18. b with single peptides. 3. Mol. Biol. 228:975-82
19. b. Science 257:919-27
20. b molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc. Natl. Acad. Sci. USA 89:8403-7
21. b at 2.4 Å resolution: implications for antigendeterminant selection. Cell 76:39-50
22. Gorga JC, Horejsí V, Johnson DR, Raghupathy R, Strominger JL. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262:16087-94
23. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39
24. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-21
25. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi Y-I, Stauffacher C, Strominger JL, Wiley DC. 1994. The three-dimensional structure of a human class II histocompatibility molecule:superantigen complex. Nature 368:711-18
26. Lawlor DA, Zemmour J, Ennis PD, Parham P. 1990. Evolution of class-IMHC genes and proteins. Annu. Rev. Immunol. 8:23-63
27. Hedrick PW, Whittam TS, Parham P. 1991. Heterozygosity at individual amino acid sites: extremely high levels for HLA-A and B genes. Proc. Natl. Acad. Sci. USA 88:5897-901
28. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512-18
29. Bjorkman PJ, Parham P. 1990. Structure, function and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59:253-88
30. Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 332:845-50
31. Engelhard VH. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13-23
32. Rötzschke O, Falk K. 1994. Origin, structure and motifs of naturally processed MHC class II ligands. Curr. Opin. Immunol. 6:45-51
33. Sinigaglia F, Hammer J. 1994. Defining rules for the peptide-MHC class II interaction. Curr. Opin. Immunol. 6:52-56
34. Madden DR, Wiley DC. 1992. Peptide binding to the major histocompatibility complex molecules. Curr. Opin. Struct. Biol. 2:300-4
35. Matsumura M, Fremont DH, Peterson PA, Wilson IA. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927-34
36. Guo H-C, Madden DR, Silver ML, Jardetzky TS, Gorga JC, Strominger JL, Wiley DC. 1993. Comparison of the P2 specificity pocket in three human histocompatibility antigens, HLA-A*6801, HLA-A*0201, and HLA-B*2705. Proc. Natl. Acad. Sci. USA 90:8053-57
37. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. 1991. Identifi-cation of self peptides bound to purified HLA-B27. Nature 353:326-29
38. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-66
39. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264-66
40. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee H-G. 1991. Allelespecifie motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-96
41. Van Bleek GM, Nathenson SG. 1991. The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self peptides. Proc. Natl. Acad. Sci. USA 88:11032-36
42. Parker KC, Biddison WE, Coligan JE. 1994. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding. Biochemistry 33:7736-43
43. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CEM, Gotch RM, Gao XM, Takiguchi MBMG, Townsend ARM, McMichael AJ, Whittle HC. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-39
44. Huczko EL, Bodnar WM, Benjamin D, Sakaguchi K, Zhu NZ, Shabanowitz J, Henderson RA, Appella E, Hunt DF, Engelhard VH. 1994. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J. Immunol. 151:2572-87
45. Falk K, Rötzschke O, Grahovac B, Schendel D, Stevanovic S, Gnau V, Jung G, Strominger JL, Rammensee H-G. 1993. Allele-specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci. USA 90:12005-9
46. Sutton J, Rowland-Jones S, Rosenberg W, Nixon D, Gotch F, Gao X-M, Murray N, Spoonas A, Driscoll P, Smith M, Willis A, McMichael A. 1993. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447-53
47. Jardetzky TS, Gorga JC, Busch R, Rothbard J, Strominger JL, Wiley DC. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9:1797-803
48. Hammer J, Takacs B, Sinigaglia F. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176:1007-13
49. 86 HLA-DRβ dimorphism in autoantigen presentation to human T cells. Proc. Natl. Acad. Sci. USA 88:7343-47
50. Bednarek MA, Sauma SY, Gammon MC, Porter G, Tamhankar S, Williamson AR, Zweerink HJ. 1991. The minimum peptide epitope from the influenza virus matrix protein. J. Immunol. 147:4047-53
51. Morrison J, Elvin J, Latron F, Goten F, Moots R, Strominger JL, McMichael A. 1992. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur. J. Immunol. 22:903-7
52. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929-37
53. Bouvier M, Wiley DC. 1994. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265:398-402
54. Saito Z, Peterson PA, Matsumura M. 1993. Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding. J. Biol. Chem. 268:21309-17
55. Wei M, Cresswell P. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443-46
56. Boehncke W-H, Takeshita T, Pendleton CD, Houghten RA, Sadegh-Nasseri S, Racioppi L, Berzofsky JA, Germain RN. 1993. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J. Immunol. 150:331-41
57. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764-68
58. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197-203
59. Parker FCC, Bednarek MA, Hull LK, Utz U, Cunningham B, Zweerink HJ, Biddison WE, Coligan JE. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule HLA-A2. J. Immunol. 149:3580-87
60. Parker KC, Bednarek MA, Coligan JE. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-75
61. O'Sullivan D, Arrhenius T, Sidney J, Del Guercio M-F, Albertson M, Wall M, Oseroff C, Southwood S, Colón SM, Gaeta FCA, Sette A. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles. J. Immunol. 147:2663-69
62. Krieger JI, Karr RW, Grey HM, Yu WY, O'Sullivan D, Batovsky L, Zheng Z-L, Colon SM, Gaeta FCA, Sidney J, Albertson M, Del Guercio M-F, Chesnut RW, Sette A. 1991. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 146:2331-40
63. Cerundolo V, Elliott T, Elvin J, Bastin J, Rammensee H-G, Townsend A. 1991. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur J. Immunol. 21:2069-75
64. Pamer EG, Wang C-R, Flaherty L, Fischer Lindahl K, Bevan MJ. 1992. H2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell 70:215-23
65. Hedrick SM. 1992. Dawn of the hunt for nonclassical MHC function. Cell 70:177-80
66. Utz U, Koenig S, Coligan JE, Biddison WE. 1992. Presentation of 3 different viral peptides, HTLV-1 TAX, HCMV gB, and influenza virus M1 is determined by common structural features of the HLA-A2.1 molecule. J. Immunol. 149:214-21
67. Chen Y, Sidney J, Southwood S, Cox AL, Sakaguchi K, Henderson RA, Appella E, Hunt DF, Sette A, Engelhard VH. 1994. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 152:2874-81
68. Urban RG, Chicz RM, Lane WS, Strominger JL, Rehm A, Kenter MJH, UytdeHaag FGCM, Ploegh H, Uchanska-Ziegler B, Ziegler A. 1994. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad Sci. USA 91:1534-38
69. Ajitkumar P, Geier SS, Kesari KV, Borriello F, Nakagawa M, Bluestone JA, Saper MA, Wiley DC, Nathenson SG. 1988. Evidence that multiple residues on both the α-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell 54:47-56
70. b molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus. Proc. Natl Acad. Sci. USA 89:3135-39
71. Jorgensen JL, Reay PA, Ehrich EW, Davis MM. 1992. Molecular components of T-cell recognition. Annu. Rev. Immunol. 10:835-73
72. Jorgensen JL, Esser U, Fezekas de St. Groth B, Reay PA, Davis MM. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain TCR transgenics. Nature 355:224-30
73. Chothia C, Boswell DR, Lesk AM. 1988. The outline structure of the T-cell αβ receptor. EMBO J. 7:3745-55
74. Davis MM, Bjorkman PJ. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334:395-402
75. Hong S-C, Chelouche A, Lin R-H, Shaywitz D, Braunstein NS, Glimcher L, Janeway CA Jr. 1992. An MHC interaction site maps to the amino-terminal half of the T cell receptor a chain variable domain. Cell 69:999-1009
76. Herman A, Kappler JW, Marrack P, Pullen AM. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-72
77. Bowness P, Allen RL, McMichael AJ. 1994. Identification of T cell receptor recognition residues for a viral peptide presented by HLA-B27. Eur. J. Immunol. In press
78. Sette A, Buus S, Colon S, Smith JA, Miles C, Grey HM. 1987. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 328:395-99
79. Chen W, McCluskey J, Rodda S, Carbone FR. 1993. Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition. J. Exp. Med. 177:869-73
80. Zimmerman N, Rötzschke O, Falk K, Rognan D, Folkers G, Rammensee H-G, Jung G. 1992. Molecular modeling of the class I human histocompatibility molecule HLA-A2 presenting an allele-specific nonapeptide from influenza matrix protein. Ang. Chem. Int. Ed. 31:886-90
81. Rognan D, Zimmerman N, Jung G, Folkers G. 1992. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein. Eur. J. Biochem. 208:101-13
82. Sezerman U, Vajda S, Cornette J, DeLisi C. 1993. Toward computational determination of peptide-receptor structure. Protein Sci. 2:1827-43
83. Driscoll PC, Altman JD, Boniface JJ, Sakaguchi K, Reay PA, Omichinski JG, Appella E, Davis MM. 1993. Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to a class II major histocompatibility complex molecule. J. Mol. Biol. 232:342-50
84. Catipovic B, Dal Porto J, Mage M, Johansen TE, Schneck JP. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611-18
85. Bluestone JA, Jameson S, Miller S, Dick RI. 1992. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176:1757-61
86. Hogquist KA, Grandea AGI, Bevan MJ. 1993. Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur. J. Immunol. 23:3028-36
87. Germain RN. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-99
88. König R, Huang L-Y, Germain RN. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356:796-98
89. 2 domain of HLA-DR molecules. Nature 356:799-801
90. Salter RD, Norment AM, Chen BP, Clayberger C, Krensky AM, Littman DR, Parham P. 1989. Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8. Nature 338:345-47
91. Potter TA, Rajan TV, Dick RFI, Bluestone JA. 1989. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 337:73-75
92. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TPJ, Clayberger C, Krensky AM, Norment AM, Liftman DR, Parham P. 1990. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 345:41-46
93. Connolly JM, Hansen TH, Ingold AL, Potter TA. 1990. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I α3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc. Natl. Acad. Sci. USA 87:2137-41
94. Parham P, Lomen CE, Lawlor DA, Ways JP, Holmes N, Coppin HL, Salter RD, Wan AM, Ennis PD. 1988. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc. Natl. Acad. Sci. USA 85: 4005-9
95. Kraulis PJ. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24:946-50
96. Carson M. 1987. Ribbon models of macromolecules. J. Mol Graphics 5:103-6